Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02391870 · ClinicalTrials.gov registry record · NA

The Staying Well Study: An Open Trial of Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depression

A NA study, sponsored by University of Colorado, Boulder.

Completed
Registry status
NA
Development phase
49
Enrollment target

NCT02391870: Completed NA study, sponsored by University of Colorado, Boulder.

NCT02391870 is a NA study that has completed, run by University of Colorado, Boulder. The registered enrollment target is 49 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02391870, a NA study, has completed, sponsored by University of Colorado, Boulder.

COMPLETED
Registry status
NA
Development phase
49 participants
Enrollment target

Study Summary

Pregnant women with histories of depression are at high risk of depressive relapse during the perinatal period, and options for relapse prevention are limited. Mindfulness-based cognitive therapy (MBCT) has strong evidence among general populations but has not been studied among at risk pregnant women. This study is the first phase of a multi-phase project adapting MBCT for perinatal women (MBCT-PD). It is being conducted in a collaboration between the University of Colorado, Emory University, and Kaiser Permanente at Colorado and Georgia.

Primary Outcome

Engagement is operationalized in-part as class attendance, with completion is defined as attendance at a minimum of four classes, and daily home practice recorded daily as the number of times of practice and type of practice, which are classified as either formal or informal practice.

Interventions

  • BEHAVIORAL MBCT-PD

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2008-11
Est. Completion 2011-03
Phase NA
University of Colorado, Boulder

69 total trials

What the finished NCT02391870 record still lists

NCT02391870 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which MBCT-PD is the first listed.

NCT02391870 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02391870 about?

NCT02391870 is a clinical study titled "The Staying Well Study: An Open Trial of Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depression". Pregnant women with histories of depression are at high risk of depressive relapse during the perinatal period, and options for relapse prevention are limited. Mindfulness-based cognitive therapy (MBCT) has strong evidence among general populations but has not been studied among at risk pregnant wom...

What is the current status of trial NCT02391870?

This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2008-11. Estimated completion is 2011-03.

What interventions are being tested in trial NCT02391870?

The interventions under investigation include: MBCT-PD (BEHAVIORAL).

Who is sponsoring clinical trial NCT02391870?

This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02391870's enrollment target sits among peer trials

49 1379th of 2000 higher than 620 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02704858 · 49 participants · Phase 1

    Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

  • NCT03516708 · 49 participants · Phase 1

    Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

  • NCT03692429 · 49 participants · Phase 1

    alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

  • NCT04329494 · 49 participants · Phase 1

    PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02391870, the US trial registry maintained by the National Library of Medicine. NCT02391870 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.